Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences Group (SLS) Cash from Investing Activities: 2010-2023

Historic Cash from Investing Activities for SELLAS Life Sciences Group (SLS) over the last 10 years, with Dec 2023 value amounting to -$5.5 million.

  • SELLAS Life Sciences Group's Cash from Investing Activities was N/A to -$3.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$23.2 million, marking a year-over-year change of. This contributed to the annual value of -$5.5 million for FY2023, which is 22.22% down from last year.
  • Latest data reveals that SELLAS Life Sciences Group reported Cash from Investing Activities of -$5.5 million as of FY2023, which was down 22.22% from -$4.5 million recorded in FY2022.
  • SELLAS Life Sciences Group's 5-year Cash from Investing Activities high stood at -$4.5 million for FY2022, and its period low was -$5.5 million during FY2023.
  • Over the past 2 years, SELLAS Life Sciences Group's median Cash from Investing Activities value was -$5.0 million (recorded in 2022), while the average stood at -$5.0 million.
  • Data for SELLAS Life Sciences Group's Cash from Investing Activities shows a maximum YoY dropped of 22.22% (in 2023) over the last 5 years.
  • Over the past 2 years, SELLAS Life Sciences Group's Cash from Investing Activities (Yearly) stood at -$4.5 million in 2022, then fell by 22.22% to -$5.5 million in 2023.